The FDA has granted approval to 45 novel drugs so far this year (from January through October), signifying a substantial rise when compared to the 28 drugs approved during the corresponding period in 2022. Notably, the highest number of novel drugs approved in the United States was in 2018, with a total of 59 receiving the regulatory nod.